Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma
Since the 1980s, the development of a pharmacology based on nerve growth factor (NGF) has been postulated for the therapy of Alzheimer's disease (AD). This hypothesis was based on the rescuing effect of the neurotrophin on the cholinergic phenotype of the basal forebrain neurons, primarily comp...
Saved in:
Main Authors: | Luigi Manni (Author), Giorgio Conti (Author), Antonio Chiaretti (Author), Marzia Soligo (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Therapies for brain injury
by: Luigi Manni, et al.
Published: (2024) -
Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease
by: Jacob Kosyakovsky, et al.
Published: (2021) -
Intranasal Delivery of Targeted Nanoparticles Loaded With miR-132 to Brain for the Treatment of Neurodegenerative Diseases
by: Yu Su, et al.
Published: (2020) -
Topical nerve growth factor prevents neurodegenerative and vascular stages of diabetic retinopathy
by: Gianpaolo Zerbini, et al.
Published: (2022) -
Antioxidant for Neurological Diseases and Neurotrauma and Bioengineering Approaches
by: Nasera Rizwana, et al.
Published: (2021)